IRIS - Res&Arch Institutional Research Information System - Research & Archive

BORDONI, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 492
EU - Europa 257
AS - Asia 246
AF - Africa 3
SA - Sud America 1
Totale 999
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 490
SG - Singapore 97
IE - Irlanda 92
IT - Italia 90
HK - Hong Kong 82
CN - Cina 32
VN - Vietnam 21
DE - Germania 20
BE - Belgio 10
FR - Francia 10
FI - Finlandia 7
RU - Federazione Russa 7
KR - Corea 6
NL - Olanda 5
AT - Austria 4
UA - Ucraina 4
CA - Canada 2
CI - Costa d'Avorio 2
GB - Regno Unito 2
SE - Svezia 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
IR - Iran 1
LB - Libano 1
MA - Marocco 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 999
Salva come PNG Salva come JPEG
Città #
Chandler 130
Dublin 88
Hong Kong 82
Singapore 81
Boardman 35
Ann Arbor 34
Perugia 31
Santa Clara 30
San Mateo 28
Dong Ket 21
Medford 16
Princeton 16
Altamura 15
Brussels 10
Lawrence 10
Wilmington 10
Redwood City 9
Munich 8
Ashburn 7
Los Angeles 7
Beijing 6
Dallas 6
Seoul 6
Andover 5
Florence 5
Saint Petersburg 5
Den Haag 4
Helsinki 4
Naples 4
Bologna 3
Cambridge 3
Des Moines 3
Frankfurt am Main 3
Houston 3
Lappeenranta 3
Vienna 3
Abidjan 2
Dearborn 2
Irpin 2
Menlo Park 2
Norwalk 2
Redmond 2
Rome 2
San Diego 2
Toronto 2
Athens 1
Avignon 1
Baku 1
Boydton 1
Brno 1
Caserta 1
Castiglione del Lago 1
Cava Dei Tirreni 1
Cormeilles-en-Parisis 1
Ercolano 1
Esslingen am Neckar 1
Fremont 1
Guiyang 1
Handan 1
Harbin 1
Hefei 1
Jacksonville 1
Jinan 1
Magdeburg 1
Milan 1
Nanjing 1
Newark 1
Philadelphia 1
Qingdao 1
Rabat 1
Radeberg 1
Riyadh 1
San Paolo di Civitate 1
Seattle 1
São Paulo 1
Tallinn 1
Tenhult 1
Timisoara 1
Woodbridge 1
Yerevan 1
Zanjan 1
Zhengzhou 1
Totale 789
Salva come PNG Salva come JPEG
Nome #
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 76
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 66
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 57
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 53
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 52
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 47
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 47
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 46
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 44
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 43
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 40
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 39
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 38
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 37
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 37
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 37
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 35
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 34
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 32
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 29
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 28
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 25
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 25
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 17
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 17
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 16
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 10
Modeling Inflammatory Bowel Disease by Intestinal Organoids 10
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 8
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 6
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 3
Totale 1.054
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 4 7 3 5 7 6 2
2020/202184 6 0 3 3 23 9 6 3 0 7 2 22
2021/2022129 4 23 1 5 1 1 13 24 2 16 13 26
2022/2023388 27 60 4 32 39 43 0 17 143 1 14 8
2023/2024195 8 17 3 5 12 1 51 26 17 8 26 21
2024/2025213 7 41 29 40 41 55 0 0 0 0 0 0
Totale 1.054